Analysts Set Bioline RX Ltd (BLRX) Target Price at $3.25

Retrieved on: 2018-03-04 02:45:00

Tags for this article:

Economy

Short

Securities research

Bioline

BIOLINE RX Ltd

Click the tags to see associated articles and topics

Analysts Set Bioline RX Ltd (BLRX) Target Price at $3.25. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC raised its position in shares of Bioline RX Ltd (NASDAQ:BLRX) by 60.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 434,700 shares of the biotechnology company's stock after ...</div>

Article found on:

View Original Article